1. Trading Members are hereby informed that Marksans Pharma Limited (Scrip code: 524404) has announced buyback of its fully paid-up equity shares of face value of Re. 1/- each from the Open Market through electronic trading mechanism of the Exchange. The Maximum Buyback Price would not exceed Rs. 60/- (Sixty Rupees only) per equity share payable in cash for an aggregate amount not exceeding Rs. 60 crores (Sixty Crores rupees Only).
2. Proposed timetable for buyback:
|
Date of Opening of the Buyback
|
Friday, July 15, 2022
|
|
Last Date for the Buyback
|
Earlier of:
a) January 14, 2023 (i.e., 6 (six) months from the date of the opening of the Buyback; or
b) when the Company completes the Buyback by deploying the amount equivalent to the Maximum Buyback Size; or
c) at such earlier date as may be determined by the Board (including a committee thereof, constituted by the Board or persons nominated by the Board/committee to exercise its powers, and/or the powers conferred by the Board resolution in relation to the Buyback), after giving notice of such earlier closure, subject to the Company having deployed an amount equivalent to the Minimum Buyback Size (even if the maximum Buyback Size has not been reached or the Maximum Buyback Shares have not been bought back), however, that all payment obligations relating to the Buyback shall be completed before the last date for the Buyback.
|
3. Broker Members for buyback:
The company has appointed the following BSE Trading Members through whom the purchases and settlement on account of the buyback would be made:
|
Name of the Member
|
Clearing No
|
|
Eureka Stock & Share Broking Services Limited
|
0906
|
4. Details of Shares held in DEMAT Form.
The Trading Members may note that the Equity Shares held in DEMAT form can be offered for Buyback to the Company in rolling settlement, as per details mentioned below:
|
Scrip Code No
|
524404
|
|
Market Lot
|
1 Share
|
|
Scrip ID
|
MARKSANS*
|
5. Circuit Filters, Margins, Capital Adequacy Norms, Auction, Close out, Bad Delivery, Arbitration, etc. are applicable in case of buyback as in the case of the normal trading.
6. Institutional Investors are allowed to participate in the buyback.
7. The documents are available in Department of Corporate Services for inspection. In case of any queries /clarifications on the scheme of buyback, Trading Members may please contact the under mentioned persons:
Bigshare Services Private Limited
S6-2, 6th Floor, Pinnacle Business Park
Next to Ahura Centre, Mahakali Caves Road
Andheri (East), Mumbai - 400 093
Tel No.: : +91 22 6283 8200
E-mail: investor@bigshareonline.com
- Merchant Banker to the Buyback:
Sundae Capital Advisors Private Limited
Level 11, Platina, Plot No. C - 59
‘G’ Block, Bandra Kurla Complex
Bandra (East), Mumbai - 400 051
Maharashtra, India
Tel.: +91 22 6884 1336 / 1337
Contact Person: Janil Jain / Ridima Gulati
Email: : marksans.buyback@sundaecapital.com
Harshavardhan Panigrahi
11th Floor, Grandeur
Veera Desai Extension Road
Oshiwara, Andheri (West)
Mumbai - 400 053, Maharashtra, India
Email: harshavardhan@marksanspharma.com
Tel: +91 22 4001 2000
· At the Exchange:
Clearing & Settlement Department -
Mr. Nilesh Shah/Ajay Darji - Extn: 022-2272-8704/8468 (For Clearing & Settlement)
Trading Department -
Trading Operations - Extn: 022-2272- 8376 (For Trading Related)
Help desk - Extn: 61363100 (Hunting) (For BOLT System)
Listing Operations Department –
Mr. Raghavendra Bhat - Extn: 022-2272-8915 (For General Queries)
Rupal Khandelwal
Assistant General Manager
Thursday, July 14, 2022 |